Indian Journal of Urology Users online:180  
IJU
Home Current Issue Ahead of print Editorial Board Archives Symposia Guidelines Subscriptions Login 
Print this page  Email this page Small font sizeDefault font sizeIncrease font size
This article has been cited by
1Interleukin (IL)-8 polymorphisms and risk of prostate disorders
Mohammad Taheri,Rezvan Noroozi,Arash Dehghan,Golnaz Atri Roozbahani,Mir Davood Omrani,Soudeh Ghafouri-Fard
Gene.2019;692()22
[DOI]
2Long noncoding RNA DNM3OS promotes prostate stromal cells transformation via the miR-29a/29b/COL3A1 and miR-361/TGF1 axes
Ruizhe Wang,Mengda Zhang,Zhenyu Ou,Wei He,Lingxiao Chen,Junjie Zhang,Yao He,Ran Xu,Shusuan Jiang,Lin Qi,Long Wang
Aging.2019;11(21)9442
[DOI]
3Anti-Proliferative Effects of Standardized Cornus officinalis on Benign Prostatic Epithelial Cells via the PCNA/E2F1-Dependent Cell Cycle Pathway
Bo-Ram Jin,Se-Yun Cheon,Hyo-Jung Kim,Myoung-Seok Kim,Kwang-Ho Lee,Hyo-Jin An
International Journal of Molecular Sciences.2020;21(24)9567
[DOI]
4Oncogenic transformation of human benign prostate hyperplasia with chronic cadmium exposure
Akhilesh Prajapati,Gaurav Chauhan,Harsh Shah,Sarita Gupta
Journal of Trace Elements in Medicine and Biology.2020;62(24)126633
[DOI]
5Serum Autoantibodies in Chronic Prostate Inflammation in Prostate Cancer Patients
Bettina Schlick,Petra Massoner,Angelika Lueking,Pornpimol Charoentong,Mirjam Blattner,Georg Schaefer,Klaus Marquart,Carmen Theek,Peter Amersdorfer,Dirk Zielinski,Matthias Kirchner,Zlatko Trajanoski,Mark A. Rubin,Stefan Mllner,Peter Schulz-Knappe,Helmut Klocker,Aamir Ahmed
PLOS ONE.2016;11(2)e0147739
[DOI]
6Epidemiology, Staging and Management of Prostate Cancer
Adam Barsouk,Sandeep Anand Padala,Anusha Vakiti,Azeem Mohammed,Kalyan Saginala,Krishna Chaitanya Thandra,Prashanth Rawla,Alexander Barsouk
Medical Sciences.2020;8(3)28
[DOI]
7Zinc Deficiency in Men Over 50 and Its Implications in Prostate Disorders
Ann Katrin Sauer,Hector Vela,Guillermo Vela,Peter Stark,Eduardo Barrera-Juarez,Andreas M. Grabrucker
Frontiers in Oncology.2020;10(3)28
[DOI]
8A Study of Molecular Signals Deregulating Mismatch Repair Genes in Prostate Cancer Compared to Benign Prostatic Hyperplasia
Sanmitra Basu,Subhadipa Majumder,Ankur Bhowal,Alip Ghosh,Sukla Naskar,Sumit Nandy,Subhabrata Mukherjee,Rajan Kumar Sinha,Keya Basu,Dilip Karmakar,Soma Banerjee,Sanghamitra Sengupta,Anthony W.I. Lo
PLOS ONE.2015;10(5)e0125560
[DOI]
9CD133 and CD166 as stem cell markers for predicting the possibility of developing prostatic cancer in cases of benign prostatic hyperplasia
Khalida I. Noel,Mustafa M. Ibraheem,Basim S. Ahmed,Ahmed F. Hameed,Nibras H. Khamees,Sameh S. Akkila
Biomedical & Pharmacology Journal.2019;12(3)1403
[DOI]
10Treatment options for benign prostate enlargement
Deidre Vlotman-Novinuk
Journal of Prescribing Practice.2019;1(3)130
[DOI]
11Expression Levels of IL-17A, IL-17F, IL-17RA, and IL-17RC in Prostate Cancer with Taking into Account the Histological Grade according to Gleason Scale in Comparison to Benign Prostatic Hyperplasia: In Search of New Therapeutic Options
Marlena Janiczek,Lukasz Szylberg,Paulina Antosik,Anna Kasperska,Andrzej Marszalek
Journal of Immunology Research.2020;2020(3)1
[DOI]
12Iodine Bonded with Milk Protein Inhibits Benign Prostatic Hyperplasia Development in Rats
Vladimir G. Bespalov,Valerii A. Alexandrov,Grigory V. Tochilnikov,Dmitrii ?. Lukin,Nadezhda T. Zhilinskaya,Alexandr L. Semenov,Irina N. Vasilyeva,Vladimir A. Romanov,Irina A. Tumanyan,Elena D. Ermakova,Elizaveta I. Kovalevskaya,Nadezhda V. Barakova,Denis A. Baranenko
Anti-Cancer Agents in Medicinal Chemistry.2019;19(13)1627
[DOI]
13Metformin reduces prostate cancer risk among men with benign prostatic hyperplasia: A nationwide population-based cohort study
Yu-Jui Kuo,Fung-Chang Sung,Po-Fan Hsieh,Hui-Ping Chang,Kun-Ling Wu,Hsi-Chin Wu
Cancer Medicine.2019;8(5)2514
[DOI]
14Chronic exposure to cadmium induces a malignant transformation of benign prostate epithelial cells
Balaji Chandrasekaran,Nisha R. Dahiya,Ashish Tyagi,Venkatesh Kolluru,Uttara Saran,Becca V. Baby,J. Christopher States,Ahmed Q. Haddad,Murali K. Ankem,Chendil Damodaran
Oncogenesis.2020;9(2)2514
[DOI]
15Inflammation and Nitrosative Stress Effects in Ovarian and Prostate Pathology and Carcinogenesis
Amy J. Burke,Pablo Garrido,Carol Johnson,Francis J. Sullivan,Sharon A. Glynn
Antioxidants & Redox Signaling.2017;26(18)1078
[DOI]
16Association ofANRILgene polymorphisms with prostate cancer and benign prostatic hyperplasia in an Iranian population
Mohammad Taheri,Farkhondeh Pouresmaeili,Mir Davood Omrani,Mohsen Habibi,Shaghayegh Sarrafzadeh,Rezvan Noroozi,Azadeh Rakhshan,Arezou Sayad,Soudeh Ghafouri-Fard
Biomarkers in Medicine.2017;11(5)413
[DOI]
17Evaluation of circulating tumor cell clusters for pan-cancer noninvasive diagnostic triaging
Andrew Gaya,Timothy Crook,Nicholas Plowman,Anantbhushan Ranade,Sewanti Limaye,Amit Bhatt,Raymond Page,Revati Patil,Pradip Fulmali,Vineet Datta,Prashant Kumar,Darshana Patil,Dadasaheb Akolkar
Cancer Cytopathology.2021;129(3)226
[DOI]
18Prostate-Associated Gene 4 (PAGE4): Leveraging the Conformational Dynamics of a Dancing Protein Cloud as a Therapeutic Target
Ravi Salgia,Mohit Jolly,Tanya Dorff,Clayton Lau,Keith Weninger,John Orban,Prakash Kulkarni
Journal of Clinical Medicine.2018;7(6)156
[DOI]
19Baicalin alleviates benign prostate hyperplasia through androgen-dependent apoptosis
Bo-Ram Jin,Hyo-Jin An
Aging.2020;12(3)2142
[DOI]
20Mechanistic targets for BPH and prostate cancera review
Abhishek Shah,Aarti Abhishek Shah,Nandakumar K,Richard Lobo
Reviews on Environmental Health.2020;0(0)2142
[DOI]
21Light-controlled calcium signalling in prostate cancer and benign prostatic hyperplasia
Vipin Sharma,Rita Rana,Ruma Baksi,Swapnil P. Borse,Manish Nivsarkar
Future Journal of Pharmaceutical Sciences.2020;6(1)2142
[DOI]
22The Effects of Resveratrol on Prostate Cancer through Targeting the Tumor Microenvironment
Natalie Silk,Jeremy Reich,Rahul Sinha,Shivansh Chawla,Kyla Geary,Dianzheng Zhang
Journal of Xenobiotics.2021;11(1)16
[DOI]
23HBX-6, Standardized Cornus officinalis and Psoralea corylifolia L. Extracts, Suppresses Benign Prostate Hyperplasia by Attenuating E2F1 Activation
Bo-Ram Jin,Hyo-Jung Kim,Jong-Hwan Seo,Myoung-Seok Kim,Kwang-Ho Lee,Il-Joo Yoon,Hyo-Jin An
Molecules.2019;24(9)1719
[DOI]
24Searching for the Novel Specific Predictors of Prostate Cancer in Urine: The Analysis of 84 miRNA Expression
Evgeniy Lekchnov,Evgeniya Amelina,Olga Bryzgunova,Ivan Zaporozhchenko,Mariya Konoshenko,Sergey Yarmoschuk,Ivan Murashov,Oxana Pashkovskaya,Anton Gorizkii,Aleksandr Zheravin,Pavel Laktionov
International Journal of Molecular Sciences.2018;19(12)4088
[DOI]
25Novel Insight into Differential Gene Expression and Clinical Significance of Dopamine Receptors, COMT, and IL6 in BPH and Prostate Cancer
Fatemeh Akbarian,Maryam Abolhasani,Farid Dadkhah,Farrokh Asadi,Ghasem Ahangari
Current Molecular Medicine.2019;19(8)605
[DOI]
26Multiparametric MRI evaluation in benign prostatic hyperplasia a true challenge in prostate cancer exclusion
Sandra O. Jurca,Gabriel Gluck,Ioana G. Lupescu
Oncolog-Hematolog.ro.2019;4(49)23
[DOI]
  Search 
  The Journal 
  The Association 
  Site Statistics 
  Addresses 
  e-Alerts 
  Online Submission 

Submit Articles

Alerts

Join us